Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To document the clinical outcome of Aquablation therapy for BPH patient in Canadian cohort.
Patients will be followed up for 3 years as standard of care.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Aquablation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Aquablation | Procedure | Aquablation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Maximum flow rate (Q-max) | Standard of care | Baseline |
| Post-Void Residual (PVR) volume | Standard of care | Baseline |
| Maximum flow rate (Q-max) | Standard of care | 1 month after surgery |
| Post-Void Residual (PVR) volume | Standard of care | 1 month after surgery |
| Maximum flow rate (Q-max) | Standard of care | 3 months after surgery |
| Post-Void Residual (PVR) volume | Standard of care | 3 months after surgery |
| Maximum flow rate (Q-max) | Standard of care | 6 months after surgery |
| Post-Void Residual (PVR) volume | Standard of care | 6 months after surgery |
| Maximum flow rate (Q-max) | Standard of care | 12 months after surgery |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
BPH patients treated by Aquablation
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dean Elterman | Contact | 4166035800 | 5033 | dean.elterman@uhn.ca |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Dean Elterman | Recruiting | Toronto | Ontario | M5T 2S8 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014570 | Urologic Diseases |
| ID | Term |
|---|---|
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000098944 | Aquablation |
| ID | Term |
|---|---|
| D055011 | Ablation Techniques |
| D013514 | Surgical Procedures, Operative |
| D011468 | Prostatectomy |
| D013521 | Urologic Surgical Procedures, Male |
Not provided
Not provided
Not provided
Not provided
Not provided
| Post-Void Residual (PVR) volume | Standard of care | 12 months after surgery |
| Maximum flow rate (Q-max) | Standard of care | 24 months after surgery |
| Post-Void Residual (PVR) volume | Standard of care | 24 months after surgery |
| Maximum flow rate (Q-max) | Standard of care | 36 months after surgery |
| Post-Void Residual (PVR) volume | Standard of care | 36 months after surgery |
| Prostate Volume | Standard of care | Baseline |
| Prostate Volume | Standard of care | 12 months after surgery |
| Questionnaires | IPSS | Baseline |
| Questionnaires | IPSS | 1 month after surgery |
| Questionnaires | IPSS | 3 months after surgery |
| Questionnaires | IPSS | 6 months after surgery |
| Questionnaires | IPSS | 12 months after surgery |
| Questionnaires | IPSS | 24 months after surgery |
| Questionnaires | IPSS | 36 months after surgery |
| Adverse Events | Adverse Events | Baseline |
| Adverse Events | Adverse Events | 1 day of Surgery |
| Adverse Events | Adverse Events | 1 month after surgery |
| Adverse Events | Adverse Events | 3 months after surgery |
| Adverse Events | Adverse Events | 6 months after surgery |
| Adverse Events | Adverse Events | 12 months after surgery |
| Adverse Events | Adverse Events | 24 months after surgery |
| Adverse Events | Adverse Events | 36 months after surgery |
| D013520 | Urologic Surgical Procedures |
| D013519 | Urogenital Surgical Procedures |